| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L27 domain binding | 1.29e-06 | 4 | 138 | 3 | GO:0097016 | |
| GeneOntologyMolecularFunction | TFIIH-class transcription factor complex binding | 1.42e-04 | 3 | 138 | 2 | GO:0001097 | |
| GeneOntologyMolecularFunction | quinone binding | 2.05e-04 | 17 | 138 | 3 | GO:0048038 | |
| GeneOntologyMolecularFunction | integrin binding | 2.18e-04 | 175 | 138 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | OBSCN ITGA2 ITGA3 ITGAE DSCAML1 PTK2 TGFBI NRXN3 EHD1 TLN2 IL1B CNTN1 LRRFIP1 | 2.68e-04 | 599 | 138 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 2.82e-04 | 4 | 138 | 2 | GO:0047696 | |
| GeneOntologyBiologicalProcess | protein localization to basolateral plasma membrane | 1.53e-05 | 8 | 136 | 3 | GO:1903361 | |
| GeneOntologyBiologicalProcess | maintenance of epithelial cell apical/basal polarity | 4.45e-05 | 11 | 136 | 3 | GO:0045199 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 4.63e-05 | 195 | 136 | 8 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 4.63e-05 | 195 | 136 | 8 | GO:0007269 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 5.65e-05 | 259 | 136 | 9 | GO:0006836 | |
| GeneOntologyBiologicalProcess | maintenance of apical/basal cell polarity | 5.91e-05 | 12 | 136 | 3 | GO:0035090 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | RAPGEF6 LIN7C ITGA3 PTCH1 TUB LIN7A EHD3 LIN7B NRXN3 EHD1 LRRC7 | 1.14e-04 | 422 | 136 | 11 | GO:1990778 |
| GeneOntologyBiologicalProcess | axon guidance | 1.17e-04 | 285 | 136 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.20e-04 | 286 | 136 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | heart development | HSPG2 XIRP1 ITGA3 PTCH1 GRHL2 PTK2 HNRNPU TBX19 PBRM1 GRK2 NFATC1 WDR11 CBY1 ROBO2 SENP2 | 1.44e-04 | 757 | 136 | 15 | GO:0007507 |
| GeneOntologyCellularComponent | MPP7-DLG1-LIN7 complex | 2.73e-06 | 5 | 137 | 3 | GO:0097025 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DOCK1 SLC4A8 LIN7C CHD4 ITGA3 PTK2 BDNF FZD4 USP6 NRXN3 GRK2 GRK3 SYT1 ROBO2 LRRC7 SIPA1L2 CNTN1 | 2.56e-05 | 817 | 137 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | neuron to neuron synapse | SLC4A8 LIN7C CHD4 BDNF LIN7A LIN7B USP6 GRK2 GRK3 SYT11 SYT1 ROBO2 LRRC7 | 4.11e-05 | 523 | 137 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | presynapse | RPL32 SLC4A8 LIN7C ITGA2 ITGA3 BDNF LIN7A LIN7B SLC6A3 NRXN3 SEPTIN3 GRK2 GRK3 SYT11 SYT1 SV2C CNTN1 | 7.02e-05 | 886 | 137 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | synaptic membrane | SLC4A8 LIN7C ITGA3 LIN7A LIN7B SLC6A3 NRXN3 SEPTIN3 SYT11 SYT1 ROBO2 LRRC7 CNTN1 | 1.23e-04 | 583 | 137 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | ciliary pocket membrane | 1.27e-04 | 3 | 137 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 1.27e-04 | 3 | 137 | 2 | GO:0020016 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GALNT3 ITGA2 ITGA3 PTCH1 TESK1 PTK2 BDNF EPG5 EHD3 ZNF675 GRK3 NFATC1 SYT11 EHD1 EIF2AK3 HMGCLL1 MYO16 | 1.33e-04 | 934 | 137 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | anchoring junction | HSPG2 XIRP1 AOC1 LIN7C OBSCN LAMA3 ITGA2 ITGA3 GRHL2 PTK2 LIN7A EHD3 FZD4 LIN7B RND3 TLN2 LRRC7 | 2.24e-04 | 976 | 137 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | asymmetric synapse | SLC4A8 LIN7C CHD4 LIN7A LIN7B USP6 GRK2 GRK3 SYT11 ROBO2 LRRC7 | 3.12e-04 | 477 | 137 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | dopaminergic synapse | 3.87e-04 | 22 | 137 | 3 | GO:0098691 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.92e-04 | 277 | 137 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | cell-cell junction | XIRP1 AOC1 LIN7C OBSCN LAMA3 GRHL2 PTK2 LIN7A FZD4 LIN7B TLN2 LRRC7 | 5.24e-04 | 591 | 137 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | axon | SLC4A8 KIF21A ITGA2 ITGA3 PTCH1 DSCAML1 BDNF SLC6A3 GRK2 GRK3 SYT11 SYT1 ROBO2 LRRC7 CNTN1 | 7.57e-04 | 891 | 137 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear body | DOCK1 MAGEA3 NRIP1 OBSCN TDG RBM39 PTK2 HNRNPU HIRA NFATC1 CBY1 SENP2 ZFHX3 MAML2 MORC3 | 8.67e-04 | 903 | 137 | 15 | GO:0016604 |
| GeneOntologyCellularComponent | basal part of cell | 8.83e-04 | 378 | 137 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | intercalated disc | 1.04e-03 | 68 | 137 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | integrin complex | 1.19e-03 | 32 | 137 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.25e-03 | 320 | 137 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | PML body | 1.41e-03 | 125 | 137 | 5 | GO:0016605 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.85e-03 | 10 | 137 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.36e-03 | 354 | 137 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 2.62e-03 | 443 | 137 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | adherens junction | 2.77e-03 | 212 | 137 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | postsynapse | DOCK1 RPL32 LIN7C ITGA3 PTK2 LIN7A LIN7B SLC6A3 USP6 GRK2 GRK3 SYT11 ROBO2 LRRC7 CNTN1 | 2.80e-03 | 1018 | 137 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density | 2.95e-03 | 451 | 137 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | fascia adherens | 3.17e-03 | 13 | 137 | 2 | GO:0005916 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 3.23e-03 | 293 | 137 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 3.41e-03 | 94 | 137 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.78e-03 | 157 | 137 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | neuron projection terminus | 4.40e-03 | 233 | 137 | 6 | GO:0044306 | |
| Domain | PbH1 | 7.27e-06 | 6 | 135 | 3 | SM00710 | |
| Domain | PbH1 | 7.27e-06 | 6 | 135 | 3 | IPR006626 | |
| Domain | Pectin_lyase_fold/virulence | 2.01e-05 | 8 | 135 | 3 | IPR011050 | |
| Domain | L27_C | 4.27e-05 | 10 | 135 | 3 | IPR014775 | |
| Domain | L27 | 4.27e-05 | 10 | 135 | 3 | PF02828 | |
| Domain | UPF0028 | 5.19e-05 | 2 | 135 | 2 | PS01237 | |
| Domain | EHD1/EHD3 | 5.19e-05 | 2 | 135 | 2 | IPR029951 | |
| Domain | L27 | 1.00e-04 | 13 | 135 | 3 | SM00569 | |
| Domain | L27 | 1.00e-04 | 13 | 135 | 3 | PS51022 | |
| Domain | L27_dom | 1.00e-04 | 13 | 135 | 3 | IPR004172 | |
| Domain | - | 1.55e-04 | 3 | 135 | 2 | 2.70.98.20 | |
| Domain | Cu_amine_oxidase_N3 | 1.55e-04 | 3 | 135 | 2 | IPR015802 | |
| Domain | Cu_amine_oxidase_N2 | 1.55e-04 | 3 | 135 | 2 | IPR015800 | |
| Domain | CASH | 1.55e-04 | 3 | 135 | 2 | SM00722 | |
| Domain | COPPER_AMINE_OXID_1 | 1.55e-04 | 3 | 135 | 2 | PS01164 | |
| Domain | COPPER_AMINE_OXID_2 | 1.55e-04 | 3 | 135 | 2 | PS01165 | |
| Domain | Cu_amine_oxidN2 | 1.55e-04 | 3 | 135 | 2 | PF02727 | |
| Domain | Cu_amine_oxidN3 | 1.55e-04 | 3 | 135 | 2 | PF02728 | |
| Domain | Cu_amine_oxidase_N-reg | 1.55e-04 | 3 | 135 | 2 | IPR016182 | |
| Domain | Cu_amine_oxid | 1.55e-04 | 3 | 135 | 2 | PF01179 | |
| Domain | Carb-bd_sugar_hydrolysis-dom | 1.55e-04 | 3 | 135 | 2 | IPR006633 | |
| Domain | Cu_amine_oxidase_C | 1.55e-04 | 3 | 135 | 2 | IPR015798 | |
| Domain | Integrin_alpha_C_CS | 1.93e-04 | 16 | 135 | 3 | IPR018184 | |
| Domain | Integrin_alpha-2 | 2.78e-04 | 18 | 135 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 2.78e-04 | 18 | 135 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 2.78e-04 | 18 | 135 | 3 | PF08441 | |
| Domain | Integrin_alpha | 2.78e-04 | 18 | 135 | 3 | IPR000413 | |
| Domain | Cu_amine_oxidase | 3.08e-04 | 4 | 135 | 2 | IPR000269 | |
| Domain | Int_alpha | 3.29e-04 | 19 | 135 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 3.29e-04 | 19 | 135 | 3 | IPR013519 | |
| Domain | Ig_I-set | 4.67e-04 | 190 | 135 | 7 | IPR013098 | |
| Domain | I-set | 4.67e-04 | 190 | 135 | 7 | PF07679 | |
| Domain | EHD_N | 5.11e-04 | 5 | 135 | 2 | IPR031692 | |
| Domain | EHD_N | 5.11e-04 | 5 | 135 | 2 | PF16880 | |
| Domain | FG_GAP | 5.14e-04 | 22 | 135 | 3 | PS51470 | |
| Domain | PDZ | 5.63e-04 | 141 | 135 | 6 | PF00595 | |
| Domain | FG-GAP | 6.69e-04 | 24 | 135 | 3 | PF01839 | |
| Domain | FG-GAP | 6.69e-04 | 24 | 135 | 3 | IPR013517 | |
| Domain | VWA | 7.17e-04 | 56 | 135 | 4 | PF00092 | |
| Domain | PDZ | 7.26e-04 | 148 | 135 | 6 | SM00228 | |
| Domain | Integrin_dom | 7.56e-04 | 25 | 135 | 3 | IPR032695 | |
| Domain | Pectin_lyas_fold | 7.63e-04 | 6 | 135 | 2 | IPR012334 | |
| Domain | E1_dh | 7.63e-04 | 6 | 135 | 2 | PF00676 | |
| Domain | - | 7.63e-04 | 6 | 135 | 2 | 2.160.20.10 | |
| Domain | DH_E1 | 7.63e-04 | 6 | 135 | 2 | IPR001017 | |
| Domain | - | 7.79e-04 | 150 | 135 | 6 | 2.30.42.10 | |
| Domain | PDZ | 8.07e-04 | 151 | 135 | 6 | PS50106 | |
| Domain | Laminin_G | 8.19e-04 | 58 | 135 | 4 | IPR001791 | |
| Domain | PDZ | 8.35e-04 | 152 | 135 | 6 | IPR001478 | |
| Domain | GPCR_kinase | 1.06e-03 | 7 | 135 | 2 | IPR000239 | |
| Domain | ConA-like_dom | 1.08e-03 | 219 | 135 | 7 | IPR013320 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.41e-03 | 8 | 135 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.41e-03 | 8 | 135 | 2 | PF10569 | |
| Domain | LAMININ_IVA | 1.41e-03 | 8 | 135 | 2 | PS51115 | |
| Domain | Laminin_B | 1.41e-03 | 8 | 135 | 2 | PF00052 | |
| Domain | MacrogloblnA2_CS | 1.41e-03 | 8 | 135 | 2 | IPR019742 | |
| Domain | LamB | 1.41e-03 | 8 | 135 | 2 | SM00281 | |
| Domain | A2M_N_2 | 1.41e-03 | 8 | 135 | 2 | SM01359 | |
| Domain | - | 1.41e-03 | 8 | 135 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.41e-03 | 8 | 135 | 2 | SM01361 | |
| Domain | A2M | 1.41e-03 | 8 | 135 | 2 | SM01360 | |
| Domain | Laminin_IV | 1.41e-03 | 8 | 135 | 2 | IPR000034 | |
| Domain | IGc2 | 1.62e-03 | 235 | 135 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.62e-03 | 235 | 135 | 7 | IPR003598 | |
| Domain | Patatin | 1.81e-03 | 9 | 135 | 2 | PF01734 | |
| Domain | PNPLA | 1.81e-03 | 9 | 135 | 2 | PS51635 | |
| Domain | Patatin/PLipase_A2-rel | 1.81e-03 | 9 | 135 | 2 | IPR002641 | |
| Domain | cNMP | 1.88e-03 | 34 | 135 | 3 | SM00100 | |
| Domain | cNMP_binding | 1.88e-03 | 34 | 135 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 2.04e-03 | 35 | 135 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 2.04e-03 | 35 | 135 | 3 | PS50042 | |
| Domain | IGv | 2.13e-03 | 75 | 135 | 4 | SM00406 | |
| Domain | A2M | 2.25e-03 | 10 | 135 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.25e-03 | 10 | 135 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.25e-03 | 10 | 135 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.25e-03 | 10 | 135 | 2 | PF07677 | |
| Domain | A2M_comp | 2.25e-03 | 10 | 135 | 2 | PF07678 | |
| Domain | A2M_N | 2.25e-03 | 10 | 135 | 2 | PF01835 | |
| Domain | A2M_N | 2.25e-03 | 10 | 135 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.25e-03 | 10 | 135 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.25e-03 | 10 | 135 | 2 | PS00477 | |
| Domain | EF-hand_4 | 2.25e-03 | 10 | 135 | 2 | PF12763 | |
| Domain | A2M_N_2 | 2.25e-03 | 10 | 135 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.25e-03 | 10 | 135 | 2 | IPR001599 | |
| Domain | cNMP-bd-like | 2.59e-03 | 38 | 135 | 3 | IPR018490 | |
| Domain | LAM_G_DOMAIN | 2.59e-03 | 38 | 135 | 3 | PS50025 | |
| Domain | EH | 2.73e-03 | 11 | 135 | 2 | PS50031 | |
| Domain | EH | 2.73e-03 | 11 | 135 | 2 | SM00027 | |
| Domain | EH_dom | 2.73e-03 | 11 | 135 | 2 | IPR000261 | |
| Domain | VWFA | 2.95e-03 | 82 | 135 | 4 | PS50234 | |
| Domain | Laminin_G_2 | 3.00e-03 | 40 | 135 | 3 | PF02210 | |
| Domain | VWA | 3.22e-03 | 84 | 135 | 4 | SM00327 | |
| Domain | - | 3.26e-03 | 12 | 135 | 2 | 1.50.10.20 | |
| Domain | THDP-binding | 3.84e-03 | 13 | 135 | 2 | IPR029061 | |
| Domain | - | 3.84e-03 | 13 | 135 | 2 | 3.40.50.970 | |
| Domain | LamG | 3.94e-03 | 44 | 135 | 3 | SM00282 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.46e-03 | 14 | 135 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.46e-03 | 14 | 135 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.46e-03 | 14 | 135 | 2 | IPR013602 | |
| Domain | G_DYNAMIN_dom | 4.46e-03 | 14 | 135 | 2 | IPR030381 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.58e-05 | 23 | 108 | 4 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.58e-05 | 23 | 108 | 4 | M12627 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 6.73e-05 | 56 | 108 | 5 | M27616 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.66e-05 | 30 | 108 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.66e-05 | 30 | 108 | 4 | M27216 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 7.66e-05 | 30 | 108 | 4 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 7.66e-05 | 30 | 108 | 4 | M47718 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.86e-04 | 15 | 108 | 3 | MM14965 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.65e-04 | 41 | 108 | 4 | M27778 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 2.91e-04 | 42 | 108 | 4 | MM15677 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 3.49e-04 | 44 | 108 | 4 | M27934 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.88e-04 | 19 | 108 | 3 | MM15512 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.59e-04 | 84 | 108 | 5 | M7098 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 5.40e-04 | 87 | 108 | 5 | M27617 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 6.17e-04 | 51 | 108 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 6.17e-04 | 51 | 108 | 4 | MM14499 | |
| Pubmed | 2.37e-10 | 4 | 138 | 4 | 18286632 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 17923534 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 14596909 | ||
| Pubmed | NYAP2 SLC4A8 KIF21A SPATA20 CHD4 PTK2 HNRNPU HIRA EHD3 FRY PBRM1 SEPTIN3 SYT1 TLN2 LRRC7 CNTN1 LRRFIP1 | 3.00e-07 | 963 | 138 | 17 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 NRIP1 CPAMD8 SRD5A3 ACACA OBSCN LAMA3 GRHL2 RBM39 PTK2 HNRNPU DNAH1 EHD3 PNPLA6 GRK3 NFATC1 WDR11 ARID5B ZFHX3 LRRC7 PNPLA7 | 4.52e-07 | 1489 | 138 | 21 | 28611215 |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 11104771 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 10341223 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 17237226 | ||
| Pubmed | NRIP1 USP13 KIF21A ETS2 FBXO11 CHD4 MED13L DSCAML1 PTK2 SPRYD7 FRY SEPTIN3 ARID5B TLN2 ZNF841 MORC3 ZMYM5 LRRFIP1 B4GALT3 | 8.42e-07 | 1285 | 138 | 19 | 35914814 | |
| Pubmed | NRIP1 ZNF536 RAPGEF6 ACACA LCORL CHD4 TXNL1 BUB1 ARID5B ZFHX3 ZMYM5 | 9.74e-07 | 418 | 138 | 11 | 34709266 | |
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 15863617 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 RAPGEF6 ACACA OBSCN SPATA20 ITGA3 MED13L PTCH1 TESK1 LYST HIRA PNPLA6 NFATC1 TLN2 SENP2 HERC1 SIPA1L2 | 1.97e-06 | 1105 | 138 | 17 | 35748872 |
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 9753324 | ||
| Pubmed | Myosin Vb interacts with Rab8a on a tubular network containing EHD1 and EHD3. | 3.37e-06 | 8 | 138 | 3 | 17507647 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 3.88e-06 | 27 | 138 | 4 | 31541017 | |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 4.19e-06 | 60 | 138 | 5 | 29055695 | |
| Pubmed | ZNF536 FSTL5 MED13L EPG5 LRIG3 XPO5 SYT11 SENP2 LRRC7 SIPA1L2 | 5.64e-06 | 407 | 138 | 10 | 12693553 | |
| Pubmed | 7.19e-06 | 10 | 138 | 3 | 14960569 | ||
| Pubmed | 7.19e-06 | 10 | 138 | 3 | 10742111 | ||
| Pubmed | 7.83e-06 | 32 | 138 | 4 | 23154389 | ||
| Pubmed | NRIP1 ZNF536 NYAP2 LIN7C GALNT3 MUC16 ITGA3 DNAH7 FER1L6 USP6 PBRM1 ARID5B | 9.77e-06 | 638 | 138 | 12 | 31182584 | |
| Pubmed | Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. | 1.31e-05 | 12 | 138 | 3 | 10846156 | |
| Pubmed | 1.44e-05 | 77 | 138 | 5 | 21525287 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34343639 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24616281 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 37433762 | ||
| Pubmed | Mammalian BUB1 protein kinases: map positions and in vivo expression. | 1.56e-05 | 2 | 138 | 2 | 9441741 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12717361 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 8638670 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33060647 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18086666 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33821668 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19932884 | ||
| Pubmed | Synaptotagmin-1 is a Ca2+ sensor for somatodendritic dopamine release. | 1.56e-05 | 2 | 138 | 2 | 36640316 | |
| Pubmed | Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. | 1.56e-05 | 2 | 138 | 2 | 12640454 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19451201 | ||
| Pubmed | SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment. | 1.56e-05 | 2 | 138 | 2 | 26226295 | |
| Pubmed | Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice. | 1.56e-05 | 2 | 138 | 2 | 26566284 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 7545357 | ||
| Pubmed | Promoter Methylation and BDNF and DAT1 Gene Expression Profiles in Patients with Drug Addiction. | 1.56e-05 | 2 | 138 | 2 | 26160290 | |
| Pubmed | Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. | 1.56e-05 | 2 | 138 | 2 | 10198406 | |
| Pubmed | G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells. | 1.56e-05 | 2 | 138 | 2 | 11762794 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 8035170 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35939172 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18543122 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19764817 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9950675 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21176997 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27181404 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23065263 | ||
| Pubmed | SOX5 LCORL ETS2 ONECUT1 GRHL2 PKHD1L1 TBX19 PBRM1 NFATC1 ARID5B PLAGL2 ZFHX3 ZMYM5 | 2.14e-05 | 808 | 138 | 13 | 20412781 | |
| Pubmed | SOX5 HSPG2 USP13 ETS2 TDG EPG5 ZNF675 PBRM1 XPO5 HERC1 ZMYM5 | 2.56e-05 | 591 | 138 | 11 | 15231748 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.96e-05 | 220 | 138 | 7 | 35785414 | |
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 3.30e-05 | 16 | 138 | 3 | 12904471 | |
| Pubmed | Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. | 3.71e-05 | 47 | 138 | 4 | 35512705 | |
| Pubmed | MALS-3 regulates polarity and early neurogenesis in the developing cerebral cortex. | 3.99e-05 | 17 | 138 | 3 | 18403412 | |
| Pubmed | Systematic and quantitative assessment of the ubiquitin-modified proteome. | 4.19e-05 | 158 | 138 | 6 | 21906983 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19052845 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 26758421 | ||
| Pubmed | Synaptotagmin-1 is the Ca2+ sensor for fast striatal dopamine release. | 4.68e-05 | 3 | 138 | 2 | 32490813 | |
| Pubmed | Expression analysis of GRIN2B, BDNF, and IL-1β genes in the whole blood of epileptic patients. | 4.68e-05 | 3 | 138 | 2 | 30140987 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11307375 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21435467 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 30616482 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9676575 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 10085131 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18363853 | ||
| Pubmed | Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation. | 4.68e-05 | 3 | 138 | 2 | 27823583 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 22082040 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12130708 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12372459 | ||
| Pubmed | Perlecan domain V inhibits α2 integrin-mediated amyloid-β neurotoxicity. | 4.68e-05 | 3 | 138 | 2 | 21126803 | |
| Pubmed | Glycosylation modulates melanoma cell α2β1 and α3β1 integrin interactions with type IV collagen. | 4.68e-05 | 3 | 138 | 2 | 24958723 | |
| Pubmed | LIN7 regulates the filopodium- and neurite-promoting activity of IRSp53. | 4.68e-05 | 3 | 138 | 2 | 22767515 | |
| Pubmed | Insertional mutation of the motor endplate disease (med) locus on mouse chromosome 15. | 4.68e-05 | 3 | 138 | 2 | 7601440 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 30983072 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 10754297 | ||
| Pubmed | Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. | 4.68e-05 | 3 | 138 | 2 | 24776686 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 23042896 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15240572 | ||
| Pubmed | Roundabout receptor 2 maintains inhibitory control of the adult midbrain. | 4.68e-05 | 3 | 138 | 2 | 28394253 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 29030221 | ||
| Pubmed | Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation. | 4.68e-05 | 3 | 138 | 2 | 25686250 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25762688 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25808553 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19502428 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 24289209 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21491204 | ||
| Pubmed | Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes. | 4.68e-05 | 3 | 138 | 2 | 23118423 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 38488492 | ||
| Pubmed | Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. | 4.68e-05 | 3 | 138 | 2 | 7761854 | |
| Pubmed | The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors. | 4.68e-05 | 3 | 138 | 2 | 31604529 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 17869478 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 37392543 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 24019528 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 38148427 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11431366 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12121420 | ||
| Pubmed | Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans. | 4.68e-05 | 3 | 138 | 2 | 15280392 | |
| Pubmed | Interleukin-1β induces angiogenesis and innervation in human intervertebral disc degeneration. | 4.68e-05 | 3 | 138 | 2 | 20690185 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.08e-05 | 9 | 93 | 3 | 1223 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.94e-05 | 161 | 93 | 7 | 593 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.02e-04 | 18 | 93 | 3 | 1160 | |
| GeneFamily | PDZ domain containing | 1.34e-04 | 152 | 93 | 6 | 1220 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 9.20e-04 | 9 | 93 | 2 | 1234 | |
| GeneFamily | Patatin like phospholipase domain containing | 1.15e-03 | 10 | 93 | 2 | 466 | |
| GeneFamily | Fibronectin type III domain containing | 1.42e-03 | 160 | 93 | 5 | 555 | |
| GeneFamily | Dyneins, axonemal | 3.39e-03 | 17 | 93 | 2 | 536 | |
| GeneFamily | Synaptotagmins | 3.39e-03 | 17 | 93 | 2 | 765 | |
| GeneFamily | Carbonic anhydrases | 3.80e-03 | 18 | 93 | 2 | 460 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 4.68e-03 | 20 | 93 | 2 | 433 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPGEF6 SLC4A8 KIF21A ETS2 LAMA3 MED13L LYST DSCAML1 BDNF FSIP2 FRY NRXN3 GRK3 SYT1 NCOA7 SV2C ROBO2 TLN2 ZFHX3 LRRC7 HERC1 CNTN1 | 7.91e-08 | 1106 | 138 | 22 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | SLC4A8 KIF21A FBXO11 ENPP4 TUB BDNF SLC6A3 FRY NRXN3 SEPTIN3 SV2C ROBO2 ZFHX3 LRRC7 HMGCLL1 CNTN1 | 8.20e-08 | 584 | 138 | 16 | M39068 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 3.30e-06 | 169 | 138 | 8 | M39230 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP | 7.82e-06 | 190 | 138 | 8 | M9871 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 1.10e-05 | 199 | 138 | 8 | M4567 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.41e-05 | 206 | 138 | 8 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.51e-05 | 208 | 138 | 8 | MM581 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | ENPP4 TUB BDNF SLC6A3 FRY NRXN3 SV2C ROBO2 ZFHX3 LRRC7 HMGCLL1 CNTN1 | 1.82e-05 | 513 | 138 | 12 | M39069 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 3.14e-05 | 168 | 138 | 7 | M1124 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | GALNT3 ETS2 LAMA3 DGKD LYST BDNF HIRA TGFBI RND3 USP6 EHD1 RTCA ARID5B NCOA7 ZFHX3 MORC3 IL1B | 3.18e-05 | 1033 | 138 | 17 | M4196 |
| Coexpression | GU_PDEF_TARGETS_UP | 3.71e-05 | 71 | 138 | 5 | M3955 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | SLC4A8 FSTL5 KIF21A LYST FRY SEPTIN3 SV2C TLN2 ZFHX3 HMGCLL1 | 4.24e-05 | 389 | 138 | 10 | M39073 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 NRIP1 USP13 TDG MSH2 MED13L RBM39 PTK2 BDNF HIRA USP6 GTF2E2 ARID5B ZFHX3 LRRFIP1 | 4.73e-05 | 856 | 138 | 15 | M4500 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 5.23e-05 | 182 | 138 | 7 | MM993 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | HSPG2 CPAMD8 ZNF536 AOC1 ETS2 ITGA2 LYST TUB ANGPTL1 TXNL1 AOC3 | 6.28e-05 | 493 | 138 | 11 | M19391 |
| Coexpression | VEGF_A_UP.V1_DN | 7.57e-05 | 193 | 138 | 7 | M2675 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP | 8.60e-05 | 197 | 138 | 7 | M4980 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP | 8.88e-05 | 198 | 138 | 7 | M5584 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | KIF21A ENPP4 ONECUT1 BDNF FRY NRXN3 GRK3 SYT1 SV2C ROBO2 TLN2 ZFHX3 LRRC7 | 9.10e-05 | 703 | 138 | 13 | M39070 |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 9.16e-05 | 199 | 138 | 7 | M7548 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_UP | 9.20e-05 | 17 | 138 | 3 | M12027 | |
| Coexpression | GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN | 9.45e-05 | 200 | 138 | 7 | M3499 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP | 9.45e-05 | 200 | 138 | 7 | M4043 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 9.54e-05 | 429 | 138 | 10 | M45694 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | DOCK1 SOX5 HSPG2 NRIP1 GALNT3 ETS2 TDG MED13L LYST LIN7A TGFBI GRK3 SYT1 PLAGL2 ZFHX3 SIPA1L2 IL1B DHTKD1 | 1.03e-04 | 1250 | 138 | 18 | M41099 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_UP | 1.28e-04 | 92 | 138 | 5 | MM786 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_UP | 1.28e-04 | 92 | 138 | 5 | M5863 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.75e-04 | 155 | 138 | 6 | M39246 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.87e-04 | 466 | 138 | 10 | M13522 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL | 1.90e-04 | 54 | 138 | 4 | M45797 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NRIP1 BCKDHA CHD4 HNRNPU RND3 ARID5B PLAGL2 SENP2 ZFHX3 SIPA1L2 | 1.90e-04 | 467 | 138 | 10 | M1347 |
| Coexpression | ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF | 2.36e-04 | 232 | 138 | 7 | M2613 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.18e-05 | 278 | 135 | 10 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | cerebral cortex | GALNTL6 ZNF536 NYAP2 SLC4A8 FSTL5 KIF21A CA10 OR2L13 DSCAML1 BDNF EHD3 ZIC4 NRXN3 SEPTIN3 SYT11 SYT1 SV2C ROBO2 TLN2 LRRC7 HMGCLL1 MYO16 CNTN1 | 3.27e-05 | 1428 | 135 | 23 | cerebral cortex |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.77e-10 | 187 | 138 | 10 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | HSPG2 COL12A1 NYAP2 LAMA3 ITGA3 GRHL2 BDNF LIN7A MYO5C MYO16 | 3.97e-10 | 188 | 138 | 10 | eea652bab161f19148a883e7e3fe2523b36b3cea |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GALNTL6 COL12A1 OBSCN PKHD1L1 DSCAML1 DNAH1 TLN2 MYO16 CNTN1 | 6.40e-09 | 184 | 138 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.40e-09 | 184 | 138 | 9 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GALNTL6 COL12A1 OBSCN PKHD1L1 DSCAML1 DNAH1 TLN2 MYO16 CNTN1 | 6.40e-09 | 184 | 138 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GALNTL6 COL12A1 OBSCN PKHD1L1 DSCAML1 DNAH1 TLN2 MYO16 CNTN1 | 6.40e-09 | 184 | 138 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.71e-09 | 185 | 138 | 9 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 7.37e-09 | 187 | 138 | 9 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.28e-09 | 192 | 138 | 9 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.28e-09 | 192 | 138 | 9 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.71e-09 | 193 | 138 | 9 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-08 | 195 | 138 | 9 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.66e-08 | 159 | 138 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-08 | 175 | 138 | 8 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.16e-08 | 179 | 138 | 8 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.09e-07 | 183 | 138 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-07 | 185 | 138 | 8 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.23e-07 | 186 | 138 | 8 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-07 | 188 | 138 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.34e-07 | 188 | 138 | 8 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-07 | 193 | 138 | 8 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.63e-07 | 193 | 138 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.70e-07 | 194 | 138 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-07 | 197 | 138 | 8 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.91e-07 | 197 | 138 | 8 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.99e-07 | 198 | 138 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-07 | 199 | 138 | 8 | ce8dbfd969b3b9c08e1c57c2bfd899818e878731 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.15e-07 | 200 | 138 | 8 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.15e-07 | 200 | 138 | 8 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.15e-07 | 200 | 138 | 8 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.21e-06 | 174 | 138 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 180 | 138 | 7 | fa819df81fca95c2cc602fede635cb03e3f35fad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 180 | 138 | 7 | 907cd510fd2e21532ce04ba687e8894f7af71f27 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-06 | 181 | 138 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.64e-06 | 182 | 138 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-06 | 182 | 138 | 7 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-06 | 184 | 138 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-06 | 184 | 138 | 7 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-06 | 184 | 138 | 7 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.76e-06 | 184 | 138 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.83e-06 | 185 | 138 | 7 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-06 | 186 | 138 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-06 | 186 | 138 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-06 | 186 | 138 | 7 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-06 | 187 | 138 | 7 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.96e-06 | 187 | 138 | 7 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-06 | 188 | 138 | 7 | e9cef856a96a97afac5ecafe2ee91eff0d731e01 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-06 | 188 | 138 | 7 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-06 | 188 | 138 | 7 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.10e-06 | 189 | 138 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-06 | 189 | 138 | 7 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.10e-06 | 189 | 138 | 7 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.18e-06 | 190 | 138 | 7 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-06 | 190 | 138 | 7 | bdbfaced785db79ff965f332759be258dbf743cf | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 190 | 138 | 7 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.18e-06 | 190 | 138 | 7 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 190 | 138 | 7 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.18e-06 | 190 | 138 | 7 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.18e-06 | 190 | 138 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 191 | 138 | 7 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron|World / Primary Cells by Cluster | 2.26e-06 | 191 | 138 | 7 | 4dd9c8117c4499ed9bde127baf2598603a82080d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-06 | 191 | 138 | 7 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-06 | 191 | 138 | 7 | 73b15ffa60d592c43aaa575f1b1479d49a66dfe8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-06 | 191 | 138 | 7 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.34e-06 | 192 | 138 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-06 | 192 | 138 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-06 | 192 | 138 | 7 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-06 | 194 | 138 | 7 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.50e-06 | 194 | 138 | 7 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 194 | 138 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.50e-06 | 194 | 138 | 7 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-06 | 194 | 138 | 7 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-06 | 194 | 138 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-06 | 194 | 138 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 2.59e-06 | 195 | 138 | 7 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-06 | 195 | 138 | 7 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.59e-06 | 195 | 138 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.68e-06 | 196 | 138 | 7 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.68e-06 | 196 | 138 | 7 | afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 2.77e-06 | 197 | 138 | 7 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-06 | 127 | 138 | 6 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-06 | 198 | 138 | 7 | b58138581f1a9073267d64c1211c5b9b4de71d3e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-06 | 198 | 138 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-06 | 198 | 138 | 7 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-06 | 199 | 138 | 7 | b4824d3683a4e3025b8e74a0f1755b331b2a0ba7 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.96e-06 | 199 | 138 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-06 | 199 | 138 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | f268cb1bb047e88913a828614b0a77871f5f8814 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 138 | 7 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.06e-06 | 200 | 138 | 7 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 7345cc7dc24b9174541a3e68ecac8c4c092be400 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.06e-06 | 200 | 138 | 7 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-06 | 200 | 138 | 7 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-06 | 148 | 138 | 6 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-06 | 148 | 138 | 6 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-06 | 153 | 138 | 6 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.74e-07 | 193 | 137 | 10 | 2332_DN | |
| Drug | Grgesp | 5.21e-06 | 42 | 137 | 5 | CID000492974 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 7.43e-06 | 28 | 133 | 4 | DOID:5409 (is_implicated_in) | |
| Disease | chronotype measurement | DOCK1 SOX5 ZNF536 LCORL KIF21A NAGA MED13L CA10 DNAH1 NRXN3 ROBO2 SHCBP1L EIF2AK3 HMGCLL1 MYO16 | 1.11e-05 | 882 | 133 | 15 | EFO_0008328 |
| Disease | creatinine measurement | SOX5 DMGDH NYAP2 OBSCN SPATA20 GRHL2 TUB FRY NFATC1 RTCA ARID5B SYT1 NCOA7 SENP2 ZFHX3 PNPLA7 | 1.11e-05 | 995 | 133 | 16 | EFO_0004518 |
| Disease | body surface area | SOX5 AOC1 LCORL MED13L PTCH1 BDNF SPRYD7 NRXN3 NCOA7 SENP2 ZFHX3 EIF2AK3 | 3.61e-05 | 643 | 133 | 12 | EFO_0022196 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.12e-05 | 139 | 133 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | SOX5 NYAP2 FBXO11 CA10 PTK2 BDNF ZIC4 NRXN3 ARID5B ROBO2 ZFHX3 HERC1 SIPA1L2 | 7.07e-05 | 801 | 133 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | lung adenocarcinoma (is_implicated_in) | 7.14e-05 | 49 | 133 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | urate measurement, bone density | FSTL5 ETS2 DGKD CA10 DNAH1 FSIP2 RND3 A2ML1 ARID5B MAML2 MYO16 | 1.19e-04 | 619 | 133 | 11 | EFO_0003923, EFO_0004531 |
| Disease | risk-taking behaviour | SOX5 ZNF536 LCORL FBXO11 PTCH1 CA10 BDNF ZIC4 NRXN3 PBRM1 ARID5B ZFHX3 | 1.84e-04 | 764 | 133 | 12 | EFO_0008579 |
| Disease | smoking status measurement | GALNTL6 NYAP2 SLC4A8 MTERF1 FBXO11 CA10 PTK2 BDNF ZIC4 NRXN3 ARID5B ROBO2 ZFHX3 HERC1 CNTN1 | 2.41e-04 | 1160 | 133 | 15 | EFO_0006527 |
| Disease | acylcarnitine measurement | 2.82e-04 | 127 | 133 | 5 | EFO_0005059 | |
| Disease | glucagon measurement, glucose tolerance test | 2.99e-04 | 6 | 133 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Junctional Epidermolysis Bullosa | 2.99e-04 | 6 | 133 | 2 | C0079301 | |
| Disease | cortical surface area measurement | SOX5 CPAMD8 ZNF536 NYAP2 LCORL MED13L PTCH1 DNAH7 ZNF675 RND3 ZIC4 SYT1 ROBO2 TLN2 ZFHX3 MYO16 | 3.75e-04 | 1345 | 133 | 16 | EFO_0010736 |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 4.17e-04 | 7 | 133 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Subwakefullness Syndrome | 4.17e-04 | 7 | 133 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 4.17e-04 | 7 | 133 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 4.17e-04 | 7 | 133 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 4.17e-04 | 7 | 133 | 2 | C0751508 | |
| Disease | Sleep Wake Disorders | 4.17e-04 | 7 | 133 | 2 | C4042891 | |
| Disease | Sleep Disorders | 4.17e-04 | 7 | 133 | 2 | C0851578 | |
| Disease | response to interferon-beta | 4.17e-04 | 7 | 133 | 2 | GO_0035456 | |
| Disease | vital capacity | HSPG2 NYAP2 AOC1 LCORL AK9 PTCH1 BDNF TXNL1 ARID5B SYT1 SENP2 ZFHX3 EIF2AK3 HMGCLL1 MYO16 | 4.69e-04 | 1236 | 133 | 15 | EFO_0004312 |
| Disease | pack-years measurement, systolic blood pressure | 4.84e-04 | 34 | 133 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | lung volume | 5.55e-04 | 8 | 133 | 2 | EFO_0600046 | |
| Disease | cystitis (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:1679 (implicated_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 5.91e-04 | 227 | 133 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | comparative body size at age 10, self-reported | 6.57e-04 | 420 | 133 | 8 | EFO_0009819 | |
| Disease | Schizophrenia | SOX5 NRIP1 RAPGEF6 CHD4 BDNF SLC6A3 NRXN3 PBRM1 WDR11 SYT11 IL1B MYO16 | 6.71e-04 | 883 | 133 | 12 | C0036341 |
| Disease | age-related hearing impairment | 6.89e-04 | 324 | 133 | 7 | EFO_0005782 | |
| Disease | Paroxysmal atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 8.10e-04 | 160 | 133 | 5 | C0004238 | |
| Disease | urinary metabolite measurement | 8.78e-04 | 245 | 133 | 6 | EFO_0005116 | |
| Disease | hip circumference | 8.83e-04 | 338 | 133 | 7 | EFO_0005093 | |
| Disease | depressive disorder (is_marker_for) | 8.86e-04 | 10 | 133 | 2 | DOID:1596 (is_marker_for) | |
| Disease | alpha wave measurement, electroencephalogram measurement | 8.86e-04 | 10 | 133 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | brain measurement, neuroimaging measurement | 8.98e-04 | 550 | 133 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | multisite chronic pain | 9.15e-04 | 95 | 133 | 4 | EFO_0010100 | |
| Disease | smoking behavior | 9.29e-04 | 341 | 133 | 7 | EFO_0004318 | |
| Disease | lymphocyte count | NRIP1 NYAP2 AOC1 ACACA LCORL DGKD MED13L GRHL2 LYST PBRM1 SEPTIN3 NFATC1 SYT11 ARID5B ROBO2 MORC3 | 9.33e-04 | 1464 | 133 | 16 | EFO_0004587 |
| Disease | diastolic blood pressure, systolic blood pressure | AOC1 MTERF1 FBXO11 DNAH7 LRIG3 ARID5B TLN2 ZFHX3 HMGCLL1 LRRFIP1 | 9.43e-04 | 670 | 133 | 10 | EFO_0006335, EFO_0006336 |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 9.68e-04 | 43 | 133 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 9.89e-04 | 97 | 133 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | total blood protein measurement | 1.01e-03 | 449 | 133 | 8 | EFO_0004536 | |
| Disease | interleukin-6 measurement, response to stimulus | 1.08e-03 | 11 | 133 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Malignant neoplasm of breast | NRIP1 XIRP1 OBSCN ETS2 TP53I3 TESK1 EPG5 SLC6A3 IGBP1 PBRM1 LRRC7 IL1B LRRFIP1 | 1.16e-03 | 1074 | 133 | 13 | C0006142 |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.29e-03 | 12 | 133 | 2 | C1861063 | |
| Disease | Colorectal Carcinoma | CPAMD8 ACACA FSTL5 OBSCN MSH2 DSCAML1 FZD4 NFATC1 BUB1 CNTN1 | 1.34e-03 | 702 | 133 | 10 | C0009402 |
| Disease | Alcoholic Intoxication, Chronic | 1.39e-03 | 268 | 133 | 6 | C0001973 | |
| Disease | corneal endothelial cell measurement | 1.47e-03 | 108 | 133 | 4 | EFO_0010079 | |
| Disease | alcohol consumption measurement | DOCK1 SOX5 COL12A1 NYAP2 SLC4A8 ACACA LCORL MTERF1 FBXO11 BDNF ZIC4 NRXN3 ARID5B ZFHX3 | 1.47e-03 | 1242 | 133 | 14 | EFO_0007878 |
| Disease | mood disorder | 1.52e-03 | 13 | 133 | 2 | EFO_0004247 | |
| Disease | hyperglycemia (is_marker_for) | 1.52e-03 | 13 | 133 | 2 | DOID:4195 (is_marker_for) | |
| Disease | systolic blood pressure, cigarettes per day measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0006335, EFO_0006525 | |
| Disease | rhinitis (biomarker_via_orthology) | 1.52e-03 | 13 | 133 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | Congestive heart failure | 1.57e-03 | 110 | 133 | 4 | C0018802 | |
| Disease | Heart failure | 1.57e-03 | 110 | 133 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.57e-03 | 110 | 133 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.57e-03 | 110 | 133 | 4 | C0235527 | |
| Disease | Heart Decompensation | 1.57e-03 | 110 | 133 | 4 | C1961112 | |
| Disease | Myocardial Failure | 1.57e-03 | 110 | 133 | 4 | C1959583 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 1.59e-03 | 51 | 133 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | TPE interval measurement | 1.68e-03 | 52 | 133 | 3 | EFO_0004644 | |
| Disease | nervous system disorder | 1.78e-03 | 53 | 133 | 3 | C0027765 | |
| Disease | Drug habituation | 1.85e-03 | 115 | 133 | 4 | C0013170 | |
| Disease | Drug abuse | 1.85e-03 | 115 | 133 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.85e-03 | 115 | 133 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.85e-03 | 115 | 133 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.85e-03 | 115 | 133 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.85e-03 | 115 | 133 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.85e-03 | 115 | 133 | 4 | C0029231 | |
| Disease | testosterone measurement | SOX5 ZNF536 NYAP2 AOC1 LCORL FBXO11 ONECUT1 TBX19 NFATC1 WDR11 ARID5B ZFHX3 HMGCLL1 MYO16 | 1.88e-03 | 1275 | 133 | 14 | EFO_0004908 |
| Disease | Substance abuse problem | 1.91e-03 | 116 | 133 | 4 | C0740858 | |
| Disease | pain | 1.99e-03 | 196 | 133 | 5 | EFO_0003843 | |
| Disease | BMI-adjusted adiponectin measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0007737 | |
| Disease | Liver carcinoma | 2.17e-03 | 507 | 133 | 8 | C2239176 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.19e-03 | 57 | 133 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | colorectal health | 2.22e-03 | 201 | 133 | 5 | EFO_0008460 | |
| Disease | colorectal cancer (is_implicated_in) | 2.23e-03 | 121 | 133 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Schizoaffective disorder-bipolar type | 2.32e-03 | 16 | 133 | 2 | EFO_0009965 | |
| Disease | Astrocytosis | 2.62e-03 | 17 | 133 | 2 | C3887640 | |
| Disease | Gliosis | 2.62e-03 | 17 | 133 | 2 | C0017639 | |
| Disease | cystitis (biomarker_via_orthology) | 2.94e-03 | 18 | 133 | 2 | DOID:1679 (biomarker_via_orthology) | |
| Disease | forced expiratory volume | DMGDH LCORL AK9 PTCH1 ONECUT1 ANGPTL1 NRXN3 PBRM1 WDR11 EIF2AK3 | 3.12e-03 | 789 | 133 | 10 | EFO_0004314 |
| Disease | cerebral microbleeds | 3.28e-03 | 19 | 133 | 2 | EFO_0010059 | |
| Disease | cumulative dose response to bevacizumab | 3.28e-03 | 19 | 133 | 2 | EFO_0005944 | |
| Disease | facial asymmetry measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0009751 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 3.40e-03 | 136 | 133 | 4 | DOID:9352 (is_marker_for) | |
| Disease | Parkinson disease | 3.42e-03 | 321 | 133 | 6 | MONDO_0005180 | |
| Disease | Alcohol abuse | 3.47e-03 | 67 | 133 | 3 | C0085762 | |
| Disease | smoking cessation | 3.63e-03 | 325 | 133 | 6 | EFO_0004319 | |
| Disease | diet measurement, body mass index | 3.63e-03 | 20 | 133 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | Profound Mental Retardation | 3.67e-03 | 139 | 133 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 3.67e-03 | 139 | 133 | 4 | C0025363 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDITGLSGNPYVKVN | 321 | Q9BT88 | |
| MAGLKVYNVDGPSNN | 306 | Q8TAA9 | |
| IIGINPGLMAAYKGH | 136 | Q13569 | |
| NTMLEGNGQYTLLAP | 266 | Q15582 | |
| QGSGLAQQPYSMEKL | 666 | Q9HCE0 | |
| GVSALTPDQYLKMNG | 236 | O60512 | |
| VGTHGYMAPEVLQKG | 351 | P35626 | |
| QETGPGKKEIYMHTG | 766 | Q4VNC0 | |
| LEAHMQSYKGNDPLG | 11 | O43683 | |
| MKEANIRGQGGLAYP | 21 | P23560 | |
| HTGQVGTKLYMSPEQ | 981 | Q9NZJ5 | |
| GTKLYMSPEQIHGNS | 986 | Q9NZJ5 | |
| YANVGNLLHTAMKGG | 1076 | A8K2U0 | |
| LGLEYGSPTMNLAGQ | 36 | Q9Y3M2 | |
| YGDKQGPLHGMLINT | 1561 | Q13085 | |
| APKMVEHSQSSYGLG | 236 | Q6NUN0 | |
| AGHSVSGIYMIKPEN | 286 | O95841 | |
| VALYGGHTPAGMQTK | 356 | P19801 | |
| GHTPAGMQTKYLDVG | 361 | P19801 | |
| LQGPFHTAGLLNMGK | 96 | Q96HY7 | |
| PSLKGLNMTGYETQA | 61 | P23280 | |
| VGTHGYMAPEVLQKG | 351 | P25098 | |
| QEALAIYGGNSPAAM | 366 | Q16853 | |
| NLQKGSAGPMRLYVG | 241 | Q14498 | |
| QSVLGNSGYKHMIGL | 226 | Q9H8K7 | |
| SADGMLLYNGQKRVP | 3696 | P98160 | |
| AMALLPGGGQAQYVT | 86 | Q53FA7 | |
| MPYGSGEQNAALLAS | 781 | Q6IE37 | |
| FTISNLQYSPDMGKG | 14081 | Q8WXI7 | |
| PKDGHLLMDGGYINN | 1126 | Q8IY17 | |
| MSGPYELKALHLQGQ | 136 | P01584 | |
| LNQQLTPVAGMMGGY | 1476 | Q86U86 | |
| NVMGGKEQNSPIYIS | 121 | O14910 | |
| NIMGGKEQNSPIYIS | 106 | Q9HAP6 | |
| NIMGGKEQNSPIYIS | 106 | Q9NUP9 | |
| PLAQGTMTGLAIQYA | 106 | O95460 | |
| LNGTLTGQAYKMSDP | 216 | Q71F56 | |
| YDGLLGDNQIMPKAG | 186 | P43357 | |
| LTYQAKSFGLPGDMV | 1536 | Q16787 | |
| HNTVNLGMLPYGGIS | 1291 | Q96NW7 | |
| KLLNTSYSHNEGPGM | 996 | Q6UXM1 | |
| AVYSPMKDGNGNVAL | 881 | Q9Y6X6 | |
| KMSVSKAQGIYGVPH | 541 | Q8N3X6 | |
| GKTMVQGKNYGPQIT | 4461 | Q15751 | |
| QTMKGNSYLPEGSFL | 3256 | Q5CZC0 | |
| KPSIMYVNTGQGLSH | 971 | P38570 | |
| TRNMAQAKVFGAGYP | 246 | P78318 | |
| GYTMQVGSFILHPKN | 251 | P26006 | |
| SDKVTMNGHVPVGLY | 86 | Q14149 | |
| GMQTQNYPKGGLLDS | 206 | P15036 | |
| QKLGDHGYDNSLPSM | 331 | Q9Y6X5 | |
| NPGKYNILGTNTIMD | 521 | Q00839 | |
| TPYHKDVAGMGQSLS | 166 | Q9UBC0 | |
| YPVVGGKKMVLSGHN | 606 | O95644 | |
| GLAQGMYSNLPKLVA | 996 | Q9Y4C0 | |
| DVGSYQLPKGMSSHL | 311 | P48552 | |
| HENYGLMPLNGSLRK | 266 | O60774 | |
| KMVNAAVNTYGAAPG | 486 | Q9P242 | |
| NPLMYLTGVQTDKAG | 1001 | P17301 | |
| GHLLMDGGYINNLPA | 1076 | Q6ZV29 | |
| QDSGLFGQYLMTPSK | 801 | Q8N475 | |
| SLMENYPGTLQALGE | 5881 | Q5VST9 | |
| HSPGNGLFNMGLKEV | 251 | Q8IZL2 | |
| VPMDGRNAYITGKNL | 181 | Q9H8P0 | |
| LGYNVTKMPNLVGHE | 56 | Q9ULV1 | |
| LNPKSITMGQLYGEF | 1901 | Q9P2D7 | |
| KQGEGPMTYLNKGQF | 261 | Q6ISB3 | |
| YGNLMENQDLLGSPT | 1811 | Q14185 | |
| VANLPYKGGNTLTGM | 1266 | Q99715 | |
| HMYSGVQIRTGSNPK | 661 | Q86XK2 | |
| PGSNGQYSIVEMKAT | 1031 | Q8TD84 | |
| GENNQGGKPLIMYTC | 521 | Q14435 | |
| MALNGKPVGAQYLPS | 426 | Q8IZJ3 | |
| YSMVGGNLVINNPDK | 91 | Q12860 | |
| NPKSVTMGQLYGQFD | 1646 | Q8WXX0 | |
| SQKYPGILNSKAMGL | 1411 | Q99698 | |
| LNMNKVLAGLYNPGD | 176 | Q9UI17 | |
| NTKILYPNVRAGMSG | 716 | Q16760 | |
| EGYLGPNTGNMHIVA | 211 | Q5TBA9 | |
| QHGIPVMNLSDGKAY | 831 | P54198 | |
| KEHLVNISGGPMTYS | 111 | Q9NS85 | |
| ATGGTLHPYQMEGLN | 721 | Q14839 | |
| DNKPMVLLVGQYSTG | 56 | Q9H4M9 | |
| QGVIKYMGPAGAKNL | 61 | P43246 | |
| YMGPAGAKNLQSVVL | 66 | P43246 | |
| ELGGYLSNLHKMGAP | 111 | P0C7X4 | |
| SDTLNNVGYQGPTKM | 266 | Q32MZ4 | |
| NISDLGKGRQMPVHY | 181 | P12694 | |
| PVSYDQGANMAKQIG | 156 | P61587 | |
| TVPKMAYNFLSGQKG | 76 | Q8N349 | |
| NGLGLNTGVNLYKVM | 331 | Q8TB92 | |
| ASKDLLYSPVAGQMG | 736 | Q2WGJ9 | |
| SPVTLYDCHGMKGNQ | 526 | Q49A17 | |
| GGLSDPYVKIHLMQN | 306 | P21579 | |
| YLKRQGISSMQESGP | 236 | P29084 | |
| ILGPQYSGKTTLCNM | 396 | Q5TCS8 | |
| MLKLGNKSPNGISDY | 116 | Q9HC62 | |
| GQILMPNIGYGSNKK | 51 | P62910 | |
| TYGNPEGNMVAKIVS | 131 | P55808 | |
| GNSFGITPTLDKQYM | 341 | Q8TEU7 | |
| GEYQGIPSMNQAKDS | 91 | Q496J9 | |
| VVQKPHGTMEYTAGN | 106 | Q8NI08 | |
| MAGSIYPGQASLLDQ | 756 | Q05397 | |
| GKIMPNNYKNGSDDG | 866 | Q13635 | |
| GQQVPGSMSKPYHRQ | 1376 | Q9P2F8 | |
| GSMSKPYHRQGAVNK | 1381 | Q9P2F8 | |
| SNKGYGVSILQPMEQ | 586 | Q9BZQ2 | |
| PVGKGQQYHEIGRSM | 346 | Q2Y0W8 | |
| VYLNGKNMHCPASGI | 141 | Q5W111 | |
| SLLTGLPQHQNGMYG | 76 | P51688 | |
| DNKPMVLLVGQYSTG | 56 | Q9NZN3 | |
| GLVMGYSQAEAQPLL | 436 | Q9UPG8 | |
| DLTGPMNENHGLNYT | 661 | Q14865 | |
| NKKPIHMYINSPGGV | 111 | Q16740 | |
| HMYINSPGGVVTAGL | 116 | Q16740 | |
| MSLGGHPNNVVSVKY | 1381 | Q7Z4S6 | |
| PMSINSNLLGYIGID | 31 | Q9UH03 | |
| GQLLMKHYGLTEAGN | 426 | Q8TB22 | |
| LKGGTNAEMAPQIDY | 121 | O00442 | |
| SFLGYMAQKHSVPIG | 366 | Q01959 | |
| SGKSPELIMFIYSNG | 61 | A0A075B6T6 | |
| LGKAGPSMQQDFYTV | 851 | Q9HAV4 | |
| ISKGLNYLTIMAPGN | 11 | Q99551 | |
| QKTDLMGFGYSLPDQ | 1026 | Q9HCK4 | |
| YMNGGTLEQLLSSPE | 131 | Q15569 | |
| KPHAGIMSYNAISGL | 3591 | Q86WI1 | |
| MHSLYGLGLGSQQQP | 226 | P50616 | |
| KGGYNGLNQCLPTMQ | 126 | Q8TD23 | |
| LSGPVLNGQYAMSQK | 21 | O15090 | |
| YKEGPMTHKNNLTGQ | 36 | Q6ZN19 | |
| HGYGGMNLTVNLAAP | 96 | Q8N9L1 | |
| YMPSKSTGNNILVIG | 386 | Q9UJ78 | |
| QMLYAAKEGGGNPKA | 1776 | Q9Y4G6 | |
| LYAAQLAAMQVSPGG | 341 | P35711 | |
| IKMYQPLLAVGTSNG | 481 | Q9BZH6 | |
| LNGGGQIMLNSLHKY | 151 | O60806 | |
| GAKYTLGLHAGPMNL | 186 | Q53S58 | |
| LMGTKFTVYDNGVNP | 336 | P50607 | |
| AQGIGSPVYAMQDSK | 476 | Q702N8 | |
| QLVLGNAGYKQMTGL | 61 | Q499Y3 | |
| QMTKLGHGLLSGQYS | 386 | Q92995 | |
| LYELNRTNPIGMKGH | 566 | P35125 | |
| ALMGLSPGSLLQQYQ | 3351 | Q15911 | |
| KLYSMKFQGPDNGQG | 176 | O43396 | |
| AQGYPKMAAALNATG | 166 | P17050 | |
| VHSSSGPKEYLGMLQ | 1351 | Q9NQX4 |